BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Amlodipine besilate/irbesartan regulatory update

Dainippon submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for amlodipine besilate/irbesartan to treat hypertension. The product is an oral combination of amlodipine besilate,...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >